CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. Its operations are carried out through the following segments: Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Contract Sales Organization (CSO), Health Care, and Intellectual Properties Development (IPD). The CRO segment provides the professional services related to the administration of clinical study and survey upon manufacture and sale such as monitoring, data management, pharmaceutical consulting, and preclinical businesses. The CMO segment handles the contract manufacture of medical supplies for pharmaceutical companies. The CSO segment includes sale and marketing support for pharmaceutical companies. The Health Care segment provides medical and support services for health maintenance and improvement. The IPD segment involves in the development and sale of diagnostic and orphan drugs. The company was founded by Kazuo Nakamura on March 14, 1985 and is headquartered in Tokyo, Japan.
TSE